Revision Implant lands oversubscribed €4m round to take brain-powered sight implant into the clinic
Belgian neurotech ReVision Implant secures an oversubscribed €4m round to bring cortical visual prosthesis manufacturing in-house ahead of first-in-human trials in Q3 2026. Read more: Revision Implant lands oversubscribed €4m…